Cosmo Pharmaceuticals NV Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
146.00
-6.00
24.00
7.00
-2.00
-18.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
0.00
0.00
-13.00
-5.00
-5.00
-10.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
154.00
18.00
31.00
12.00
10.00
-20.00
Cash Flow from Investing Activities
-122.00
50.00
0.00
23.00
79.00
-57.00
Cash Flow from Financing Activities
-38.00
-201.00
-41.00
-24.00
-8.00
-34.00
Net Cash Inflow / Outflow
-5.00
-131.00
-12.00
13.00
80.00
-111.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
-1.00
2.00
-1.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CHF Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Cosmo Pharmaceuticals NV
Figures in Million
consolidated Cash Flow Results
Change(CHF)
Change(%)
Profit Before Tax
146.098932844349
12045.7709892927
-11,899.00
-98.79%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
0.107644926297126
-1596.65030001372
1,596.00
100.01%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
154.929627240582
15516.4818731063
-15,362.00
-99.00%
Cash Flow from Investing Activities
-122.98861503932
-6616.455435192
6,494.00
98.14%
Cash Flow from Financing Activities
-38.3177833219081
-10340.7985784672
10,302.00
99.63%
Net Cash Inflow / Outflow
-5.69565499407539
-1703.21107569031
1,698.00
99.67%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.681116126570314
-262.438935137391
262.00
100.26%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 732.12% vs -40.13% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
154.93
18.62
732.12%






